RxDoctor Payments Data

Rachel Holloway, APRN

Family · Tifton, GANPI 1013695923

Payments from drug & device makers

$895in general payments, 2019–2025

Across 50 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$188
  • Lilly USA, LLC$131
  • Ardelyx, Inc.$127
  • Pfizer$126
  • Astellas Pharma US Inc$79
  • Amgen$64
  • plus $180 from 6 others

What the payments were for

  • Food & beverage$895100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$895 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$11,277
Medicare patients
124
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$24,347
OzempicSemaglutide23$21,854
JanuviaSitagliptin Phosphate17$10,709
XareltoRivaroxaban12$7,570
Levothyroxine Sodium51$682
Atorvastatin Calcium66$575
Gabapentin41$489
Pantoprazole Sodium34$443
Montelukast Sodium29$438
Pravastatin Sodium17$345
Omeprazole34$340
Fluticasone Propionate25$333
Levocetirizine Dihydrochloride16$237
Doxycycline Hyclate19$202
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$131$24,34721 claims
Novo NordiskOzempic$188$21,85423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,258 family providers in Georgia.

Other family in Tifton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →